• 1
    Dawood FS, Subbarao K, Fiore AE. Influenza viruses; in Long SS, Pickering LK, Prober CG, (eds): Principles and Practice of Pediatric Infectious Diseases, 4th edn. Philadelphia: Elsevier, 2012; 11491159.
  • 2
    Perez-Padilla R, de la Rosa-Zamboni D, Ponce de Leon S et al. Pneumonia and respiratory failure from swine-origin influenza A (H1N1) in Mexico. N Engl J Med 2009; 361:680689.
  • 3
    Lin JC, Nichol KL. Excess mortality due to pneumonia or influenza during influenza seasons among persons with acquired immunodeficiency syndrome. Arch Intern Med 2001; 161:441446.
  • 4
    Radwan HM, Cheeseman SH, Lai KK et al. Influenza in human immunodeficiency virus-infected patients during the 1997–1998 influenza season. Clin Infect Dis 2000; 31:604606.
  • 5
    Klein MB, Lu Y, DelBalso L et al. Influenzavirus infection is a primary cause of febrile respiratory illness in HIV-infected adults, despite vaccination. Clin Infect Dis 2007; 45:234240.
  • 6
    Cooper CL. Pandemic H1N12009 influenza and HIV: a review of natural history, management and vaccine immunogenicity. Curr Opin Infect Dis 2012; 25:2635.
  • 7
    Kok J, Tudo K, Blyth CC et al. Pandemic (H1N1) 2009 influenza virus seroconversion rates in HIV-infected individuals. J Acquir Immune Defic Syndr 2011; 56:9194.
  • 8
    Feiterna-Sperling C, Edelmann A, Nickel R et al. Pandemic influenza A (H1N1) outbreak among 15 school-aged HIV-1-infected children. Clin Infect Dis 2010; 51:e90e94.
  • 9
    Noguera-Julian A, Provens AC, Soler-Palacin P et al. Pandemic influenza a (2009 H1N1) in human immunodeficiency virus-infected catalan children. Pediatr Infect Dis J 2011; 30:173175.
  • 10
    Martinez E, Marcos MA, Hoyo-Ulloa I et al. Influenza A H1N1 in HIV-infected adults. HIV Med 2011; 12:236245.
  • 11
    Riera M, Payeras A, Marcos MA et al. Clinical presentation and prognosis of the 2009 H1N1 influenza A infection in HIV-1-infected patients: a Spanish multicenter study. AIDS 2010; 24:24612467.
  • 12
    Peters PJ, Skarbinski J, Louie JK et al. HIV-infected hospitalized patients with 2009 pandemic influenza A (pH1N1) – United States, spring and summer 2009. Clin Infect Dis 2011; 52(Suppl 1):S183S188.
  • 13
    Ormsby CE, de la Rosa-Zamboni D, Vazquez-Perez J et al. Severe 2009 pandemic influenza A (H1N1) infection and increased mortality in patients with late and advanced HIV disease. AIDS 2011; 25:435439.
  • 14
    Launay O, Desaint C, Durier C et al. Safety and immunogenicity of a monovalent 2009 influenza A/H1N1v vaccine adjuvanted with AS03A or unadjuvanted in HIV-infected adults: a randomized, controlled trial. J Infect Dis 2011; 204:124134.
  • 15
    Bickel M, von Hentig N, Wieters I et al. Immune response after two doses of the novel split virion, adjuvanted pandemic H1N1 influenza A vaccine in HIV-1-infected patients. Clin Infect Dis 2011; 52:122127.
  • 16
    Vigano A, Giacomet V, Pariani E et al. Long-term immunogenicity after one and two doses of a monovalent MF59-adjuvanted A/H1N1 Influenza virus vaccine coadministered with the seasonal 2009-2010 nonadjuvanted Influenza virus vaccine in HIV-infected children, adolescents, and young adults in a randomized controlled trial. Clin Vaccine Immunol 2011; 18:15031509.
  • 17
    Palma P, Romiti ML, Bernardi S et al. Safety and immunogenicity of a monovalent MF59(R)-adjuvanted A/H1N1 vaccine in HIV-infected children and young adults. Biologicals 2012; 40:134139.
  • 18
    Esposito S, Tagliaferri L, Daleno C et al. Pandemic influenza A/H1N1 vaccine administered sequentially or simultaneously with seasonal influenza vaccine to HIV-infected children and adolescents. Vaccine 2011; 29:16771682.
  • 19
    Phongsamart W, Sirisanthana V, Wittawatmongkol O et al. Immunogenicity and safety of monovalent influenza A (H1N1) 2009 in HIV-infected Thai children. Vaccine 2011; 29:87058711.
  • 20
    Strategic Advisory Group of Experts on Immunization – report of the extraordinary meeting on the influenza A (H1N1) 2009 pandemic, 7 July 2009. Wkly Epidemiol Rec 2009; 84:301304.
  • 21
    Okike IO, Yung C, Ladhani S et al. The immunogenicity of a novel A (H1N1) vaccine in HIV-infected children. Vaccine 2011; 29:66366640.
  • 22
    Hannoun C, Megas F, Piercy J. Immunogenicity and protective efficacy of influenza vaccination. Virus Res 2004; 103:133138.
  • 23
    Tebas P, Frank I, Lewis M et al. Poor immunogenicity of the H1N1 2009 vaccine in well controlled HIV-infected individuals. AIDS 2010; 24:21872192.
  • 24
    Evison J, Farese S, Seitz M et al. Randomized, double-blind comparative trial of subunit and virosomal influenza vaccines for immunocompromised patients. Clin Infect Dis 2009; 48:14021412.
  • 25
    de Carvalho AP, Dutra LC, Tonelli E. [Influenza vaccination in HIV infected children: immunologic and viral load changes]. J Pediatr (Rio J) 2003; 79:2940.
  • 26
    Gunthard HF, Wong JK, Spina CA et al. Effect of influenza vaccination on viral replication and immune response in persons infected with human immunodeficiency virus receiving potent antiretroviral therapy. J Infect Dis 2000; 181:522531.
  • 27
    Sullivan PS, Hanson DL, Dworkin MS et al. Effect of influenza vaccination on disease progression among HIV-infected persons. AIDS 2000; 14:27812785.
  • 28
    Macias J, Pineda JA, Leal M et al. HIV-1 plasma viremia not increased in patients receiving highly active antiretroviral therapy after influenza vaccination. Eur J Clin Microbiol Infect Dis 2001; 20:4648.
  • 29
    Skiest DJ, Machala T. Comparison of the effects of acute influenza infection and influenza vaccination on HIV viral load and CD4 cell counts. J Clin Virol 2003; 26:307315.